Yahoo Finance • 3 months ago
Tvardi Therapeutics, Inc. (NASDAQ:TVRD) announced Monday that Shaheen Wirk resigned from its board of directors on July 8. According to a statement from the company, Dr. Wirk’s decision to step down was not the result of any disagreement w... Full story
Yahoo Finance • 3 months ago
Investing.com - Cantor Fitzgerald initiated coverage on Tvardi Therapeutics Inc (NASDAQ:TVRD) with an Overweight rating and a price target of $52.00 on Friday. The $212 million market cap company currently trades at $22.67, with analysts s... Full story
Yahoo Finance • 4 months ago
* Tvardi Therapeutics (NASDAQ:TVRD [https://seekingalpha.com/symbol/TVRD]) files to sell 2.08M shares of common stock for holders. * Filing [https://seekingalpha.com/filing/10046911] MORE ON TVARDI THERAPEUTICS * Historical earning... Full story